Page last updated: 2024-08-26

fulvestrant and canertinib

fulvestrant has been researched along with canertinib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benjaminsen, RV; Christiansen, IJ; Emdal, KB; Frogne, T; Kirkegaard, T; Lykkesfeldt, AE; Norrie, IC; Sonne-Hansen, K	1

Other Studies

1 other study(ies) available for fulvestrant and canertinib

Article	Year
Breast cancer cells can switch between estrogen receptor alpha and ErbB signaling and combined treatment against both signaling pathways postpones development of resistance. Breast cancer research and treatment, 2010, Volume: 121, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Estradiol; Estrogen Receptor alpha; Female; Fulvestrant; Humans; Morpholines; Oncogene Proteins v-erbB; Signal Transduction	2010

Article

Year

Breast cancer cells can switch between estrogen receptor alpha and ErbB signaling and combined treatment against both signaling pathways postpones development of resistance.

Breast cancer research and treatment, 2010, Volume: 121, Issue:3

Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Estradiol; Estrogen Receptor alpha; Female; Fulvestrant; Humans; Morpholines; Oncogene Proteins v-erbB; Signal Transduction

2010